MabGenesis
Yokohama
About MabGenesis
MabGenesis is a biopharmaceutical company that provides therapeutic monoclonal antibody drugs in the human and animal fields. They have an antibody library and monoclonal antibody isolation technology. With the provision of novel antibody therapeutics, the firm helps to relieve symptoms and improve the quality of life of individuals suffering from.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.6M
- Last round: Series Unknown (Dec 2024)
- Website: mabgenesis.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/mabgenesis-145141 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.